More than $60 billion worth of patents on biological products are expiring before 2020, representing a major opportunity for the pharmaceutical industry. Read More >
Moving forward clinical studies will have to include a comparative assessment of
pharmacokinetics and immunogenicity to the original reference biologic drug Read More >
Leveraging industry best practices to protect consumer safety Read More >
(Based on 2014 Sales, in $U.S. Millions) Read More >
Implementing an acceptable clinical monitoring plan requires a thorough understanding of the new rules under which we’re operating Read More >
We exceed expectations
Welcome to Contract Pharma’s Sixteenth Annual Salary Survey!
Summary from the 12th Annual Report and Summary of Biopharmaceutical Manufacturing Capacity and Production
(Based on 2014 Sales, in $U.S. Millions)
Herein are the results of our 2015 Annual Outsourcing Survey, where we call on you, the readers.
Thursday, July 23rd, 2 pm EST
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.